Skip to main content
Cipla to price generic version of COVID-19 drug remdesivir at less than Rs 5,000 per vial - Moneycontrol 24-Jun-2020
Cipla to price generic version of COVID-19 drug remdesivir at less than Rs 5,000 per vial - Moneycontrol
Remdesivir is the only United States Food and Drug Administration (USFDA)-approved Emergency Use Authorisation (EUA) treatment for adult and paediatric patients hospitalised with suspected or laboratory confirmed COVID-19 infection.
More...